E & E CRO Consulting - Referenzen

Aktuelle Studien

Ausgewählte Referenz-Studien

 

Weitere Informationen auf Diese E-Mail-Adresse ist gegen Spambots geschützt! Sie müssen JavaScript aktivieren, damit Sie sie sehen können.

 

Aktuelle Studien:

COOLING TRIALS: 

2013 The STATIM-Trial: Strategic Target Temperature Management In Myocardial Infarction, A randomized, controlled trial of the use of a strategic temperature care bundle as an adjunct to primary percutaneous coronary intervention in acute ST-elevation acute coronary syndrome/myocardial infarction, and its effects on innate immunity
 

2008 ICTuS 2/3 Trial: Phase 2/3 Study of Intravenous Thrombolysis and Hypothermia for Acute Treatment of Ischemic Stroke (European arm)
 

2013 COOL CATH Trial: Early targeted brain cooling in the cath lab following cardiac arrest / Randomised Controlled Trial of RhinoChill versus. Blanketrol intra-hospital induction of therapeutic hypothermia after cardiac arrest
 

2011 CHILL-MI Study: Rapid Endovascular Catheter Core Cooling combined with cold saline as an Adjunct to Percutaneous Coronary Intervention For the Treatment of Acute Myocardial Infarction A Randomized, Controlled Study of the Use of Central Venous Catheter Core Cooling combined with cold saline as an Adjunct to Percutaneous Coronary Intervention For the Treatment of Acute Myocardial Infarction
 

LEFT VENTRICULAR ASSIST DEVICE TRIALS: 

2013 HeartMate ® III CE Mark Study

2013 C-Pulse Study: C-Pulse® System European Multicenter Study
 

2012 DABIGATRAN Pilot-Trial: Dabigatran as an alternative anticoagulant in patients with left ventricular assist device
 

PFO CLOSURE TRIAL:

2005 PC Trial: Randomized clinical trial comparing the efficacy of Percutaneous Closure of Patent foramen ovale (PFO) with medical treatment in patient with Cryptogenic embolism.
 

PERIPHERAL VASCULAR TRIALS:

2013 SPRINT Trial: An Evaluation of the 480 Biomedical STANZA TM Drug-Eluting Resorbable Scaffold (DRS) System in the treatment of de novo SFA Lesions
 

2012 STANCE Trial: A Safety Assessment of the 480 Biomedical Bioresorbable Scaffold System in the Treatment of de novo SFA Lesions